Market by Product and Service, Type, Application, Technology, Industry Vertical, and Regional Outlook | Forecast 2024-2032
Multiplex assay is a type of immunoassay that uses magnetic beads to simultaneously measure multiple analytes such as proteins, biomolecules, growth factors, cytokines, chemokines, and others in a single experiment. It is a derivative of an ELISA using beads for binding the capture antibody. This technique allows for the simultaneous detection of multiple analytes in a single well or reaction.
Multiplex assay provides sensitive and highly specific detection of analytes of interest in biological samples. They utilize reagents and consumables during experiments conducted in R&D labs and for disease diagnosis in clinical diagnostics labs and hospitals. For instance, Luminex offers reagents such as LX200-CAL-K25, LX200-CON-K25, xMAP Sheath Fluid, and others.
According to Triton Market Research’s report, the Global Multiplex Assay Market is likely to grow with a CAGR of 8.56% during the forecast period 2024-2032. The market gained $3905.45 million in 2023 and is expected to reach $8235.49 million by 2032.
Click here to check out our blog on the Global Multiplex Assay Market
MARKET PERFORMANCE – DRIVERS, CHALLENGES, AND OPPORTUNITIES
Factors such as the adoption of personalized medicines and the increasing prevalence of chronic conditions drive the studied market on a growth path. There are several advantages of multiplex assay such as the ability to perform multiplex analysis and gather comprehensive data in a single run, proving highly useful for the comprehensive production of personalized medicines. For instance, the administration of warfarin (used to prevent blood clots) is extremely difficult due to genetic variation in different patients and the presence of different drug metabolism enzymes. Hence, multiplex assays are used for panel-based tests that are expected to detect variations in genes in one assay cycle. Furthermore, as the prevalence of chronic diseases increases, the demand for multiplex assays further increases. These assays provide comprehensive and accurate disease profiles, enabling healthcare providers to deliver personalized treatment plans, thereby improving patient outcomes.
However, issues related to cross-reactivity and assay interference and lack of skilled workforce impede the market’s growth. Cross-reactivity and assay interference are significant challenges that can limit the performance of the assay, prevent scaling up of multiplexing, and even lead to inaccurate or false results. Cross-reactivity (CR) occurs when an antibody reacts with an unintended antigen, leading to false-positive results. This is particularly problematic in multiplex assays, where multiple analytes are measured simultaneously. The complexity of biological matrices can contribute to cross-reactivity, as they often contain related proteins, isoforms, and precursors that can interfere with the assay. These analytes often exist at radically different concentrations. Therefore, the assay must have a wide dynamic range to accurately measure all these analytes. However, many assays, such as the Enzyme-Linked Immunosorbent Assay (ELISA), have a dynamic range limited to a few orders of magnitude. This limitation makes it challenging for ELISA multiplex assay to cover the range of individual analytes.
Nevertheless, technological advancements, rapid growth of companion diagnostics, and growth in drug discovery initiatives create opportunities for the studied market. Companion diagnostics are tests or assays that assist in identifying patients who are most likely to benefit from a specific treatment or medication. These tests play a crucial role in the field of precision medicine, which aims to tailor treatments to individual patients based on their unique characteristics. These characteristics can include genetic makeup, biomarker expression, or other diagnostic criteria. By identifying these factors, healthcare providers can ensure that patients receive the most effective treatments for their specific conditions. Besides, they are particularly useful in drug discovery and development as they can provide a lot of information efficiently. This can help to speed up the drug discovery process and reduce costs.
Report scope can be customized per your requirements - Request Free Sample Report
KEY GEOGRAPHIES COVERED:
• North America: United States and Canada
• Europe: United Kingdom, France, Germany, Spain, Italy, the Netherlands, and Rest of Europe
• Asia-Pacific: China, Japan, India, South Korea, ASEAN Countries, Australia & New Zealand, and Rest of Asia-Pacific
• Latin America: Brazil, Mexico, and Rest of Latin America
• Middle East and Africa: United Arab Emirates, Saudi Arabia, Turkey, South Africa, and Rest of Middle East & Africa
SEGMENTATION ANALYSIS – MULTIPLEX ASSAY MARKET:
• Market by Product and Service:
o Reagents and Consumables
o Instruments and Accessories
o Software and Services
• Market by Type:
o Protein-Based Multiplex Assay
o Nucleic Acid-Based Multiplex Assay
o Other Multiplex Assays
In 2023, Protein-based multiplex assay led the market. These assays are used to identify and quantify proteins, widely used for the diagnosis and detection of various diseases such as cancer, infectious diseases, and others.
• Market by Application:
o Research and Development
o Clinical Diagnostics
o Companion Diagnostics
• Market by Technology:
o Multiplex Protein Microarray
o Multiplex PCR
o Other Technologies
• Market by Industry Vertical:
o Pharmaceutical & Biotechnology Companies
o Research Institutes
o Clinical Laboratories
o Hospitals
The competitive landscape helps dive into data about the key players in the multiplex assay market. The strategic initiatives for each of the companies considered have been covered in detail.
Contracts and Partnerships (January 2023): Agilent Technologies and Akoya Biosciences
Agilent Technologies and Akoya Biosciences collaborated to create multiplex immunohistochemistry assays for tissue analysis. Through this collaboration, they aimed to combine Agilent’s Dako Omnis autostaining instrument with Akoya’s PhenoImager HT imaging platform to facilitate multiplex chromogenic immunohistochemistry and immunofluorescent assays.
Acquisitions & Mergers (October 2023): Thermo Fisher Scientific Inc and Olink Holding
Thermo Fisher Scientific had an agreement to purchase Olink Holding for around $3.1 billion. This acquisition aims to enhance the buyer’s footprint in the field of proteomics. The completion of the acquisition is anticipated by mid-2024.
KEY BENEFITS OF THE REPORT:
Triton Market Research has a collective experience of 25-30 years in the industry, with its analysts and experts encompassing the most infallible research methodology for its market intelligence and industry analysis.
Our research methodology helps in achieving a broader consensus of the market size, shape, and industry trends within each industry segment.
The strategy adopted in designing the research methodology includes the amalgamation of the information assembled from primary and secondary sources, with the assistance of analytical tools to construct the forecast and predictive models.
The scope of the market report comprises the current scenario of the global multiplex assay market, along with the detailed overview of the industry outlook, market dynamics, segmentation analysis, regional outlook, and competitive landscape for the period 2024-2032.
FAQs:
Q 1) Which is the fastest-growing type in the multiplex assay market?
Nucleic acid-based multiplex assay is the fastest-growing type in the multiplex assay market.
Q 2) Which industry vertical comprises the highest market share in the multiplex assay market?
Pharmaceutical & biotechnology companies comprise the highest market share in the multiplex assay market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. GLOBAL
MULTIPLEX ASSAY MARKET- SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
ANALYSIS ON THE MULTIPLEX ASSAY MARKET
2.1.1. IMPACT
OF COVID-19 ON THE MULTIPLEX ASSAY MARKET
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE PRODUCTS
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. COMPETITIVE
RIVALRY
2.3. KEY
BUYING IMPACT ANALYSIS
2.3.1. ANALYTE
COVERAGE
2.3.2. SPEED
2.3.3. MULTIPLEXING
CAPABILITY
2.3.4. EASE
OF USE
2.3.5. AUTOMATION
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. KEY
MARKET STRATEGIES
2.5.1. CONTRACTS
AND PARTNERSHIPS
2.5.2. BUSINESS
EXPANSIONS & DIVESTITURES
2.5.3. ACQUISITIONS
& MERGERS
2.5.4. PRODUCT
LAUNCHES & DEVELOPMENTS
2.6. MARKET
DRIVERS
2.6.1. ADOPTION
OF PERSONALIZED MEDICINES
2.6.2. HIGH
ADOPTION OF MULTIPLEX ASSAYS OVER TRADITIONAL METHODS
2.6.3. INCREASING
PREVALENCE OF CHRONIC DISEASES
2.7. MARKET
CHALLENGES
2.7.1. ISSUES
RELATED TO CROSS-REACTIVITY AND ASSAY INTERFERENCE
2.7.2. CHALLENGE
IN ACHIEVING ADEQUATE ASSAY RANGE
2.7.3. DEARTH
OF SKILLED PROFESSIONALS
2.8. MARKET
OPPORTUNITIES
2.8.1. TECHNOLOGICAL
ADVANCEMENTS IN ASSAY PLATFORMS
2.8.2. RAPID
GROWTH OF COMPANION DIAGNOSTICS
2.8.3. GROWTH
IN DRUG DISCOVERY INITIATIVES
2.9. ANALYST
PERSPECTIVE
3. GLOBAL
MULTIPLEX ASSAY MARKET - BY PRODUCT AND SERVICE
3.1. REAGENTS
AND CONSUMABLES
3.2. INSTRUMENTS
AND ACCESSORIES
3.3. SOFTWARE
AND SERVICES
4. GLOBAL
MULTIPLEX ASSAY MARKET - BY TYPE
4.1. PROTEIN-BASED
MULTIPLEX ASSAY
4.2. NUCLEIC
ACID-BASED MULTIPLEX ASSAY
4.3. OTHER
MULTIPLEX ASSAYS
5. GLOBAL
MULTIPLEX ASSAY MARKET - BY APPLICATION
5.1. RESEARCH
AND DEVELOPMENT
5.2. CLINICAL
DIAGNOSTICS
5.3. COMPANION
DIAGNOSTICS
6. GLOBAL
MULTIPLEX ASSAY MARKET - BY TECHNOLOGY
6.1. MULTIPLEX
PROTEIN MICROARRAY
6.2. MULTIPLEX
PCR
6.3. OTHER
TECHNOLOGIES
7. GLOBAL
MULTIPLEX ASSAY MARKET - BY INDUSTRY VERTICAL
7.1. PHARMACEUTICAL
& BIOTECHNOLOGY COMPANIES
7.2. RESEARCH
INSTITUTES
7.3. CLINICAL
LABORATORIES
7.4. HOSPITALS
8. GLOBAL
MULTIPLEX ASSAY MARKET – BY REGIONAL OUTLOOK
8.1. NORTH
AMERICA
8.1.1. MARKET
BY PRODUCT AND SERVICE
8.1.2. MARKET
BY TYPE
8.1.3. MARKET
BY APPLICATION
8.1.4. MARKET
BY TECHNOLOGY
8.1.5. MARKET
BY INDUSTRY VERTICAL
8.1.6. COUNTRY
ANALYSIS
8.1.6.1. UNITED
STATES
8.1.6.1.1. UNITED
STATES MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.1.6.2. CANADA
8.1.6.2.1. CANADA
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2. EUROPE
8.2.1. MARKET
BY PRODUCT AND SERVICE
8.2.2. MARKET
BY TYPE
8.2.3. MARKET
BY APPLICATION
8.2.4. MARKET
BY TECHNOLOGY
8.2.5. MARKET
BY INDUSTRY VERTICAL
8.2.6. COUNTRY
ANALYSIS
8.2.6.1. GERMANY
8.2.6.1.1. GERMANY
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.2. UNITED
KINGDOM
8.2.6.2.1. UNITED
KINGDOM MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.3. FRANCE
8.2.6.3.1. FRANCE
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.4. ITALY
8.2.6.4.1. ITALY
MARKET FORECAST & PROSPECTS
8.2.6.5. SPAIN
8.2.6.5.1. SPAIN
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.6. NETHERLANDS
8.2.6.6.1. NETHERLANDS
MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.2.6.7. REST
OF EUROPE
8.2.6.7.1. REST
OF EUROPE MULTIPLEX ASSAY MARKET FORECAST & PROSPECTS
8.3. ASIA-PACIFIC
8.3.1. MARKET
BY PRODUCT AND SERVICE
8.3.2. MARKET
BY TYPE
8.3.3. MARKET
BY APPLICATION
8.3.4. MARKET
BY TECHNOLOGY
8.3.5. MARKET
BY INDUSTRY VERTICAL
8.3.6. COUNTRY
ANALYSIS
8.3.6.1. CHINA
8.3.6.1.1. CHINA
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.2. JAPAN
8.3.6.2.1. JAPAN
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.3. INDIA
8.3.6.3.1. INDIA
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.4. ASEAN
COUNTRIES
8.3.6.4.1. ASEAN
COUNTRIES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.5. AUSTRALIA
& NEW ZEALAND
8.3.6.5.1. AUSTRALIA
& NEW ZEALAND MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.6. SOUTH
KOREA
8.3.6.6.1. SOUTH
KOREA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.3.6.7. REST
OF ASIA-PACIFIC
8.3.6.7.1. REST
OF ASIA-PACIFIC MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4. LATIN
AMERICA
8.4.1. MARKET
BY PRODUCT AND SERVICE
8.4.2. MARKET
BY TYPE
8.4.3. MARKET
BY APPLICATION
8.4.4. MARKET
BY TECHNOLOGY
8.4.5. MARKET
BY INDUSTRY VERTICAL
8.4.6. COUNTRY
ANALYSIS
8.4.6.1. BRAZIL
8.4.6.1.1. BRAZIL
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4.6.2. MEXICO
8.4.6.2.1. MEXICO
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.4.6.3. REST
OF LATIN AMERICA
8.4.6.3.1. REST
OF LATIN AMERICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5. MIDDLE
EAST AND AFRICA
8.5.1. MARKET
BY PRODUCT AND SERVICE
8.5.2. MARKET
BY TYPE
8.5.3. MARKET
BY APPLICATION
8.5.4. MARKET
BY TECHNOLOGY
8.5.5. MARKET
BY INDUSTRY VERTICAL
8.5.6. COUNTRY
ANALYSIS
8.5.6.1. UNITED
ARAB EMIRATES
8.5.6.1.1. UNITED
ARAB EMIRATES MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.2. SAUDI
ARABIA
8.5.6.2.1. SAUDI
ARABIA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.3. TURKEY
8.5.6.3.1. TURKEY
MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.4. SOUTH
AFRICA
8.5.6.4.1. SOUTH
AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
8.5.6.5. REST
OF MIDDLE EAST & AFRICA
8.5.6.5.1. REST
OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET FORECAST & PROSPECTS
9. COMPETITIVE
LANDSCAPE
9.1. ABCAM
LIMITED
9.1.1. OVERVIEW
9.1.2. PRODUCT
PORTFOLIO
9.2. AGILENT
TECHNOLOGIES INC
9.2.1. OVERVIEW
9.2.2. PRODUCT
PORTFOLIO
9.2.3. KEY
STRENGTHS
9.2.4. KEY
CHALLENGES
9.3. BECTON
DICKINSON AND COMPANY (BD)
9.3.1. OVERVIEW
9.3.2. PRODUCT
PORTFOLIO
9.3.3. KEY
STRENGTHS
9.3.4. KEY
CHALLENGES
9.4. BIO-RAD
LABORATORIES INC
9.4.1. OVERVIEW
9.4.2. PRODUCT
PORTFOLIO
9.4.3. KEY
STRENGTHS
9.4.4. KEY
CHALLENGES
9.5. BIO-TECHNE
CORPORATION
9.5.1. OVERVIEW
9.5.2. PRODUCT
PORTFOLIO
9.6. F.
HOFFMANN-LA ROCHE LTD
9.6.1. OVERVIEW
9.6.2. PRODUCT
PORTFOLIO
9.6.3. KEY STRENGTHS
9.6.4. KEY CHALLENGES
9.7. ILLUMINA
INC
9.7.1. OVERVIEW
9.7.2. PRODUCT
PORTFOLIO
9.7.3. KEY STRENGTHS
9.7.4. KEY CHALLENGES
9.8. MERCK
MILLIPORE
9.8.1. OVERVIEW
9.8.2. PRODUCT
PORTFOLIO
9.9. OLINK
PROTEOMICS AB
9.9.1. OVERVIEW
9.9.2. PRODUCT
PORTFOLIO
9.10. QIAGEN
NV
9.10.1. OVERVIEW
9.10.2. PRODUCT
PORTFOLIO
9.10.3. KEY STRENGTHS
9.10.4. KEY CHALLENGES
9.11. RANDOX
LABORATORIES LTD
9.11.1. OVERVIEW
9.11.2. PRODUCT
PORTFOLIO
9.12. SEEGENE
INC
9.12.1. OVERVIEW
9.12.2. PRODUCT
PORTFOLIO
9.13. SIEMENS
HEALTHINEERS AG
9.13.1. OVERVIEW
9.13.2. PRODUCT
PORTFOLIO
9.13.3. KEY
STRENGTHS
9.13.4. KEY
CHALLENGES
9.14. THERMO
FISHER SCIENTIFIC INC
9.14.1. OVERVIEW
9.14.2. PRODUCT
PORTFOLIO
9.14.3. KEY
STRENGTHS
9.14.4. KEY
CHALLENGES
10. RESEARCH
METHODOLOGY & SCOPE
10.1. RESEARCH
SCOPE & DELIVERABLES
10.2. SOURCES
OF DATA
10.3. RESEARCH
METHODOLOGY
TABLE
1: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE
2: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS,
2024-2032 (IN $ MILLION)
TABLE
3: CONTRACTS AND PARTNERSHIPS
TABLE
4: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
TABLE
5: ACQUISITIONS & MERGERS
TABLE
6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE
7: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $
MILLION)
TABLE
8: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE
10: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE
11: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
12: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, HISTORICAL YEARS,
2020-2023 (IN $ MILLION)
TABLE
13: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, FORECAST YEARS,
2024-2032 (IN $ MILLION)
TABLE
14: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE
15: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN
$ MILLION)
TABLE
16: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
17: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $
MILLION)
TABLE
18: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $
MILLION)
TABLE
19: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
20: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $ MILLION)
TABLE
21: EUROPE MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN $
MILLION)
TABLE
22: EUROPE MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
23: EUROPE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $ MILLION)
TABLE
24: EUROPE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $ MILLION)
TABLE
25: EUROPE MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
26: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE
27: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN
$ MILLION)
TABLE
28: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
29: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $
MILLION)
TABLE
30: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $
MILLION)
TABLE
31: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
32: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2024-2032 (IN $
MILLION)
TABLE
33: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2024-2032 (IN
$ MILLION)
TABLE
34: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $ MILLION)
TABLE
35: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032 (IN $
MILLION)
TABLE
36: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN $
MILLION)
TABLE
37: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2024-2032 (IN $
MILLION)
TABLE
38: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK,
2024-2032 (IN $ MILLION)
TABLE
39: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE,
2024-2032 (IN $ MILLION)
TABLE
40: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TYPE, 2024-2032 (IN $
MILLION)
TABLE
41: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2024-2032
(IN $ MILLION)
TABLE
42: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2024-2032 (IN
$ MILLION)
FIGURE
1: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT AND SERVICE, 2023 & 2032, (IN %)
FIGURE
2: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2024-2032 (IN $
MILLION)
FIGURE
3: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2024-2032 (IN
$ MILLION)
FIGURE
4: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2024-2032 (IN $
MILLION)
FIGURE
5: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2023 & 2032 (IN %)
FIGURE
6: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAY, 2024-2032
(IN $ MILLION)
FIGURE
7: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAY,
2024-2032 (IN $ MILLION)
FIGURE
8: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2024-2032 (IN $
MILLION)
FIGURE
9: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2023 & 2032, (IN %)
FIGURE
10: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2024-2032 (IN $
MILLION)
FIGURE
11: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2024-2032 (IN $
MILLION)
FIGURE
12: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2024-2032 (IN $
MILLION)
FIGURE
13: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2023 & 2032 (IN %)
FIGURE
14: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2024-2032
(IN $ MILLION)
FIGURE
15: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2024-2032 (IN $ MILLION)
FIGURE
16: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGIES, 2024-2032 (IN $
MILLION)
FIGURE
17: GLOBAL MULTIPLEX ASSAY MARKET, BY INDUSTRY VERTICAL, 2023 & 2032, (IN %)
FIGURE
18: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY
COMPANIES, 2024-2032 (IN $ MILLION)
FIGURE
19: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2024-2032 (IN $
MILLION)
FIGURE
20: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2024-2032 (IN $
MILLION)
FIGURE
21: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2024-2032 (IN $ MILLION)
FIGURE
22: GLOBAL MULTIPLEX ASSAY MARKET, BY REGIONAL OUTLOOK, 2023 & 2032 (IN %)
FIGURE
23: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032
(IN %)
FIGURE
24: UNITED STATES MULTIPLEX ASSAY MARKET, 2024-2032 (IN $ MILLION)
FIGURE
25: CANADA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
26: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032 (IN %)
FIGURE
27: GERMANY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
28: UNITED KINGDOM MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
29: FRANCE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
30: ITALY MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
31: SPAIN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
32: NETHERLANDS MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
33: REST OF EUROPE MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
34: ASIA-PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032
(IN %)
FIGURE
35: CHINA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
36: JAPAN MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
37: INDIA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
38: ASEAN COUNTRIES MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
39: AUSTRALIA & NEW ZEALAND MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
40: SOUTH KOREA MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
41: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET 2024-2032 (IN $ MILLION)
FIGURE
42: LATIN AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023 & 2032
(IN %)
FIGURE
43: BRAZIL MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
44: MEXICO MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
45: REST OF LATIN AMERICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
46: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, BY COUNTRY OUTLOOK, 2023
& 2032 (IN %)
FIGURE
47: UNITED ARAB EMIRATES MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
48: SAUDI ARABIA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
49: TURKEY MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
50: SOUTH AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $ MILLION)
FIGURE
51: REST OF MIDDLE EAST & AFRICA MULTIPLEX ASSAYS MARKET 2024-2032 (IN $
MILLION)